check_circleStudy Completed
Multiple Sclerosis
Bayer Identifier:
14173
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Physical Disability in Patients Treated With Betaferon
Trial purpose
To gather Observation data about physical disability progression, safety and adherence during the use of Betaferon in daily practice. Patients with any type of Multiple Sclerosis (MS) (MRRS) (PSMS), under treatment with Betaferon.Open Multicentric Observational study.24 months.Evaluation of physical disability in patients treated with Betaferon, using Kurtzke's expanded disability scale (EDSS) in biannual periods
Key Participants Requirements
Sex
BothAge
18 - N/ATrial summary
Enrollment Goal
83Trial Dates
October 2007 - January 2011Phase
N/ACould I Receive a placebo
NoProducts
Betaseron (Interferon beta-1b, BAY86-5046)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Colombia |
Primary Outcome
- To collect observational local data about effectivity related to physical disability progression on the daily routine basis in patients treated with Betaferondate_rangeTime Frame:Every 6 months for 2 yearsenhanced_encryptionNoSafety Issue:
Secondary Outcome
- To evaluate Betaferon safety on the daily routine basisdate_rangeTime Frame:Every 6 monthsenhanced_encryptionYesSafety Issue:
- To evaluate patient adherence to Betaferon treatmentdate_rangeTime Frame:Every 6 monthsenhanced_encryptionNoSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A